NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3013% above fair value
$7.56−4.46 (-37.10%)
Close on Nov 13, 2026Market cap $259.49MP/E –Yield 0.00%
NeuroPace EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for NeuroPace
NeuroPace has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?